We’re Evolving—Immortality.global 2.0 is Incubating
The platform is in maintenance while we finalize a release that blends AI and longevity science like never before.

October 1 in Longevity and AI

Gathered globally: 3, selected: 3.

The News Aggregator is an artificial intelligence system that gathers and filters global news on longevity and artificial intelligence, and provides tailored multilingual content of varying sophistication to help users understand what's happening in the world of longevity and AI.


European Wellness Biomedical Group unveils the Human Cytology Atlas, mapping 400+ distinct human cell types using integrated molecular profiling. This atlas informs precision regenerative medicine by identifying cellular targets across organs, enabling therapies that restore cellspan and extend healthspan effectively.

Key points

  • Human Cytology Atlas maps 400+ human cell types via integrated single-cell transcriptomics and proteomics.
  • Mosaic organ aging study reveals differential decline across cardiovascular, immune, neural, renal, and hepatic tissues.
  • Precision protocols include intramuscular precursor cell injections and plasma proteome biomarker monitoring for targeted healthspan extension.

Why it matters: By shifting longevity strategies from organ replacement to cellular repair, this atlas paves the way for precision regenerative therapies that sustain healthspan.

Q&A

  • What is the Human Cytology Atlas?
  • How does cellular regeneration differ from organ transplantation?
  • Why map differential aging rates across organs?
  • What challenges remain for cell-based longevity therapies?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
BEYOND IMMORTALITY: European Wellness Biomedical Group Charts Longevity Through Cell Regeneration Over Organ Transplant

Towards Healthcare, a sister firm of Precedence Research, forecasts the global generative AI in life sciences market to expand from USD 250 million in 2024 to USD 1,657.02 million by 2034. Their analysis employs CAGR projections and regional segmentation to highlight AI-driven molecule and protein design accelerating drug discovery pipelines.

Key points

  • Global generative AI in life sciences market grows from USD 250 million in 2024 to USD 1,657.02 million by 2034 at a 20.82% CAGR.
  • North America holds a 42% revenue share in 2024; Asia Pacific expected to be fastest-growing region through 2034.
  • Novel molecule generation leads the technology segment; drug discovery dominates applications, with clinical trials segment showing fastest growth.

Q&A

  • What is generative AI in life sciences?
  • Why is the market growing so rapidly?
  • Which regions and segments lead adoption?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Generative AI In Life Sciences Market Size Projects USD 1,657.02 Million by 2034

Sougwen Chung’s lab develops D.O.U.G, a neural-network-based robotic art system trained on two decades of her drawings. Iterations range from style mimicry to live robotic arms drawing alongside Chung and urban-sensor-driven versions that react to city movement, probing AI’s role in creative agency.

Key points

  • D.O.U.G series trains deep neural networks on two decades of Sougwen Chung’s artwork to internalize and evolve her style.
  • D.O.U.G_2 employs a robotic hand for live, synchronous human–machine drawing performances.
  • D.O.U.G_3 integrates urban motion-vector data from surveillance feeds to drive context-aware, interactive art installations.

Why it matters: This work redefines artistic agency by demonstrating how AI-driven, interactive neural systems can transparently augment human creativity and redefine exhibitions.

Q&A

  • What is the D.O.U.G art system?
  • How do neural networks learn artistic style?
  • What are motion vectors and how are they used in art?
  • Why is the neural-network “black box” an issue?
  • What is Inductive Logic Programming (ILP)?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...
Artificial Intelligence Empowering Interactive Art Experiences